Cadence Pharmaceuticals was a San Diego-based specialty pharmaceutical company focused on developing and commercializing products for use in the hospital setting, primarily targeting acute pain management. The company's lead product was Ofirmev (IV acetaminophen). Cadence raised approximately $197 million in funding before being acquired by Mallinckrodt PLC in 2014 for approximately $1.3 billion.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2014
Jun 2010
Feb 2009
Create a free account to see which investors have funded this company.
Create Free AccountMultinational hospital network operating in South Asia and Africa providing integrated healthcare...
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...
A clinical-stage biopharma company based in Lyon, France
Clinical-stage biopharmaceutical company focused on the development of oral small molecule therap...
Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe...
Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally ava...
